Vycor Medical (VYCO) Net Income Growth (1y) (2011 - 2026)
Vycor Medical (VYCO) Net Income Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | -47.84% |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 44.34% |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 18.55% |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 13.84% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | -27.18% |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 38.54% |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 14.80% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 75.09% |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 12.92% |
| 10 | Vycor Medical | 2.34 Mn | 2.18 Mn | 344,445.00 | -193.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 126.53% |
| Dec 31, 2025 | -490.38% |
| Sep 30, 2025 | -14.89% |
| Jun 30, 2025 | -3,626.53% |
| Mar 31, 2025 | 51.49% |
| Dec 31, 2024 | 98.32% |
| Sep 30, 2024 | 88.94% |
| Jun 30, 2024 | 97.95% |
| Mar 31, 2024 | 85.71% |
| Dec 31, 2023 | -356.34% |
| Sep 30, 2023 | 82.97% |
| Jun 30, 2023 | -85.75% |
| Mar 31, 2023 | 6.36% |
| Dec 31, 2022 | 29.23% |
| Sep 30, 2022 | 37.09% |
| Jun 30, 2022 | 87.55% |
| Mar 31, 2022 | 93.47% |
| Dec 31, 2021 | -103.29% |
| Sep 30, 2021 | 69.65% |
| Jun 30, 2021 | 63.84% |